65,437 trials
Asses Immunosuppression Modulation on Renal Recovery Post LT
Primary: Participants Who Have Recovered Renal Function — 28; 20; 11 Participants
Non-Cystic Fibrosis Bronchiectasis
Primary: Annualized Rate of Pulmonary Exacerbations (PEs) — 1.015; 1.036; 1.286 exacerbation per participant-year — p==0.0019
Moderate to Severe Ulcerative Colitis
Primary: Induction Period: Percentage of Participants Who Achieved Clinical Remission at Week 14 — 11.6; 25.5; 23.3; 23.9 percentage of participants — p=0.0545
Benzodiazepine Dependence · Anxiety Disorders · Sleep Disturbance
Primary: Feasibility of Intervention — 67; 48 Percentage of participants
Age-related Cataract · Phacoemulsification
Primary: Change in Corneal Endothelial Cell Count — -441.33; -482.3 cells/mm2
Bone Density, Low · Bone Loss · Anorexia Nervosa
Primary: Percent Change From Baseline to 12 Months in Postero-anterior Lumbar Spine Bone Mineral Density by Dual Energy X-ray Absorptiometry (DXA). — 12.4; -0.3 % change…
Kidney Failure, Chronic · Peritoneal Dialysis-associated Peritonitis · Dialysis Capd Infection
Primary: Time to the First Dialysis-associated Peritonitis Episode in the Retraining Group and the Control Group — 381; 368 Days to first peritonitis episode — p=0.51
Locally Advanced Unresectable Pancreatic Adenocarcinoma · Metastatic Pancreatic Adenocarcinoma · Recurrent Pancreatic Adenocarcinoma
Primary: Weight Stability — -1.98; -5.58 Percent weight change
Tumors
Primary: Part 1: Number of Participants With Dose-limiting Toxicities (DLTs) — 0; 0; 0; 0 Participants
Fruit and Vegetable Consumption in Children
Primary: Change From Baseline Fruit and Vegetable Knowledge at 3 Months After the Evaluation Lesson — 4.1; 3.5; 3.7; 3.6 score on a scale — p=0.001
Hydrocortisone · Depression · Healthy Volunteers
Primary: Hippocampal Subfield Activation (Left Hemisphere) — -0.35; 0.03; -0.08; -0.07 Z-Score
Multiple Myeloma
Primary: Rate of Participant Enrollment — 5 Participants
Migraine
Primary: Mean Change From Observation Phase (OP) in the Number of Migraine Days Per Month Over Entire DBT Phase (Weeks 1 to 12) — -2.9; -4.0; -2.2 Days per month — p==0.0220
Neuromuscular Function · Muscle Activation · Postactivation Potentiation
Primary: Jump Height 4 Minute — 45.34; 47.41 cm
Depressive Symptoms · Aging
Primary: Urinary Flavonoid Biomarkers — 398863; 1045795 Unitless